Enhanced cellular uptake of folic acid–conjugated PLGA–PEG nanoparticles loaded with vincristine sulfate in human breast cancer

References

• van Vlerken LE, Vyas TK, Amiji MM. (2007). Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res, 24:1405–1414.
   PubMed Web of Science ®Google Scholar
• Wang Z, Chui WK, Ho PC. (2009). Design of a multifunctional PLGA nanoparticulate drug delivery system: Evaluation of its physicochemical properties and anticancer activity to malignant cancer cells. Pharm Res, 26:1162–1171.
   PubMed Web of Science ®Google Scholar
• Wang M, Thanou M. (2010). Targeting nanoparticles to cancer. Pharmacol Res, 62:90–99.
   PubMed Web of Science ®Google Scholar
• Hilgenbrink AR, Low PS. (2005). Folate receptor-mediated drug targeting: From therapeutics to diagnostics. J Pharm Sci, 94:2135–2146.
   PubMed Web of Science ®Google Scholar
• Kim S, Lee J. (2011). Folate-targeted drug-delivery systems prepared by nano-comminution. Drug Dev Ind Pharm, 37:131–138.
   PubMed Web of Science ®Google Scholar
• Saul JM, Annapragada AV, Bellamkonda RV. (2006). A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. J Control Release, 114:277–287.
   PubMed Web of Science ®Google Scholar
• Zhao D, Zhao X, Zu Y, Li J, Zhang Y, Jiang R, Zhang Z. (2010). Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomed, 5:669–677.
   PubMed Web of Science ®Google Scholar
• Stella B, Arpicco S, Peracchia MT, Desmaële D, Hoebeke J, Renoir M, D’Angelo J, Cattel L, Couvreur P. (2000). Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci, 89:1452–1464.
   PubMed Web of Science ®Google Scholar
• Cil T, Altintas A, Tamam Y, Battaloglu E, Isikdogan A. (2009). Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: A case report (vincristine-induced severe polyneuropathy). J Pediatr Hematol Oncol, 31:787–789.
   PubMed Web of Science ®Google Scholar
• Moore A, Pinkerton R. (2009). Vincristine: Can its therapeutic index be enhanced? Pediatr Blood Cancer, 53:1180–1187.
   PubMed Web of Science ®Google Scholar
• Rodriguez MA, Pytlik R, Kozak T, Chhanabhai M, Gascoyne R, Lu B, Deitcher SR, Winter JN; Marqibo Investigators. (2009). Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: Report of the pivotal phase 2 study. Cancer, 115:3475–3482.
   PubMed Web of Science ®Google Scholar
• Ravi Kumar MN, Bakowsky U, Lehr CM. (2004). Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials, 25:1771–1777.
   PubMed Web of Science ®Google Scholar
• Lü JM, Wang X, Marin-Muller C, Wang H, Lin PH, Yao Q, Chen C. (2009). Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn, 9:325–341.
   PubMed Web of Science ®Google Scholar
• Diao YY, Han M, Ding PT, Chen DW, Gao JQ. (2010). DOX-loaded PEG-PLGA and Pluronic copolymer composite micelles enhances cytotoxicity and the intracellular accumulation of drug in DOX-resistant tumor cells. Pharmazie, 65:356–358.
   PubMed Web of Science ®Google Scholar
• Kamaly N, Kalber T, Thanou M, Bell JD, Miller AD. (2009). Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging. Bioconjugate Chem, 20:648–655.
   PubMed Web of Science ®Google Scholar
• Shi G, Guo W, Stephenson SM, Lee RJ. (2002). Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J Control Release, 80:309–319.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhao P, Liang X, Gong X, Song T, Niu R, Chang J. (2010). Folate-PEG coated cationic modified chitosan–cholesterol liposomes for tumor-targeted drug delivery. Biomaterials, 31:4129–4138.
   PubMed Web of Science ®Google Scholar
• Hattori Y, Maitani Y. (2004). Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer. J Control Release, 97:173–183.
   PubMed Web of Science ®Google Scholar
• Pan J, Feng SS. (2008). Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. Biomaterials, 29:2663–2672.
   PubMed Web of Science ®Google Scholar
• Lee ES, Na K, Bae YH. (2005). Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release, 103:405–418.
   PubMed Web of Science ®Google Scholar
• Zhao H, Yung LY. (2008). Selectivity of folate conjugated polymer micelles against different tumor cells. Int J Pharm, 349:256–268.
   PubMed Web of Science ®Google Scholar
• Song XR, Cai Z, Zheng Y, He G, Cui FY, Gong DQ, Hou SX, Xiong SJ, Lei XJ, Wei YQ. (2009). Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. Eur J Pharm Sci, 37:300–305.
   PubMed Web of Science ®Google Scholar
• Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Livaniou E, Evangelatos G, Ithakissios DS. (2003). Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int J Pharm, 259:115–127.
   PubMed Web of Science ®Google Scholar
• Beletsi A, Leontiadis L, Klepetsanis P, Ithakissios DS, Avgoustakis K. (1999). Effect of preparative variables on the properties of poly(dl-lactide-co-glycolide)-methoxypoly(ethyleneglycol) copolymers related to their application in controlled drug delivery. Int J Pharm, 182:187–197.
   PubMed Web of Science ®Google Scholar
• Esmaeili F, Ghahremani MH, Ostad SN, Atyabi F, Seyedabadi M, Malekshahi MR, Amini M, Dinarvand R. (2008). Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate. J Drug Target, 16:415–423.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang S, Bei Jz. (2004). Synthesis and characterization of macroinitiator-amino terminated PEG and poly(γ-benzyl-l-glutamate)-PEO-poly(γ-benzyl-l-glutamate) triblock copolymer. Polym Advan Technol, 15: 617–621.
   Web of Science ®Google Scholar
• Yoo HS, Park TG. (2004). Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release, 96:273–283.
   PubMed Web of Science ®Google Scholar
• Cohen-Sela E, Teitlboim S, Chorny M, Koroukhov N, Danenberg HD, Gao J, Golomb G. (2009). Single and double emulsion manufacturing techniques of an amphiphilic drug in PLGA nanoparticles: Formulations of mithramycin and bioactivity. J Pharm Sci, 98:1452–1462.
   PubMed Web of Science ®Google Scholar
• Meng FT, Ma GH, Qiu W, Su ZG. (2003). W/O/W double emulsion technique using ethyl acetate as organic solvent: Effects of its diffusion rate on the characteristics of microparticles. J Control Release, 91:407–416.
   PubMed Web of Science ®Google Scholar
• Sheshala R, Peh KK, Darwis Y. (2009). Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery. Drug Dev Ind Pharm, 35:1364–1374.
   PubMed Web of Science ®Google Scholar
• Cavalli R, Donalisio M, Civra A, Ferruti P, Ranucci E, Trotta F, Lembo D. (2009). Enhanced antiviral activity of Acyclovir loaded into β-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles. J Control Release, 137:116–122.
   PubMed Web of Science ®Google Scholar
• Hu K, Li J, Shen Y, Lu W, Gao X, Zhang Q, Jiang X. (2009). Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations. J Control Release, 134:55–61.
   PubMed Web of Science ®Google Scholar
• Davda J, Labhasetwar V. (2002). Characterization of nanoparticle uptake by endothelial cells. Int J Pharm, 233:51–59.
   PubMed Web of Science ®Google Scholar
• Win KY, Feng SS. (2005). Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26:2713–2722.
   PubMed Web of Science ®Google Scholar
• Stella B, Marsaud V, Arpicco S, Géraud G, Cattel L, Couvreur P, Renoir JM. (2007). Biological characterization of folic acid-conjugated poly(H2NPEGCA-co-HDCA) nanoparticles in cellular models. J Drug Target, 15:146–153.
   PubMed Web of Science ®Google Scholar
• Wu L, Tang C, Yin C. (2010). Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Drug Dev Ind Pharm, 36:439–448.
   PubMed Web of Science ®Google Scholar
• Pinhassi RI, Assaraf YG, Farber S, Stark M, Ickowicz D, Drori S, Domb AJ, Livney YD. (2010). Arabinogalactan-folic acid-drug conjugate for targeted delivery and target-activated release of anticancer drugs to folate receptor-overexpressing cells. Biomacromolecules, 11:294–303.
   PubMed Web of Science ®Google Scholar
• Yang SJ, Lin FH, Tsai KC, Wei MF, Tsai HM, Wong JM, Shieh MJ. (2010). Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells.. Bioconjugate Chem, 21:679–689.
   PubMed Web of Science ®Google Scholar